Table 2 Three point bending of the femur two-way analysis of variance
From: Genistein treatment improves fracture resistance in obese diabetic mice
|  | Lean STD | Lean + GEN | Obese STD | Obese + GEN | Genotype effect (P) | Treatment effect (P) | Genotype * treatment interaction (P) |
|---|---|---|---|---|---|---|---|
Midshaft A-P diameter (mm) | 2.14 ± 0.05 | 2.19 ± 0.07 | 2.09 ± 0.02 | 2.15 ± 0.05 | 0.42 | 0.32 | 0.86 |
Ultimate force (N) | 13.1 ± 1.47 | 16.5 ± 1.27 | 7.4 ± 1.34 | 12.2 ± 1.61 | 0.02 | 0.01 | 0.63 |
Deformation to failure (mm) | 0.36 ± 0.02 | 0.52 ± 0.05 | 0.32 ± 0.02 | 0.46 ± 0.10 | 1.00 | 0.01 | 0.50 |
Time to failure (s) | 3.00 ± 0.55 | 3.60 ± 0.24 | 2.60 ± 0.24 | 3.40 ± 0.68 | 0.53 | 0.16 | 0.83 |
Fracture location (% femur length) | 48.3 ± 12.6 | 49.9 ± 9.4 | 38.4 ± 8.57 | 45.3 ± 10.0 | 0.49 | 0.69 | 0.80 |